The global Pharmacogenomics Market is expected to reach USD 11.97 Billion by 2027, according to a new report by Emergen Research. The global pharmacogenomics (PGx) market is growing at a substantial pace owing to the growing demand for personalized therapy, increasing prevalence of target chronic diseases, technological advancements, favorable government initiatives,...

This report studies the Pharmacogenomics Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Pharmacogenomics Market analysis segmented by companies, region, type and applications in...

Global Pharmacogenomics Market: by Technology (Polymerase Chain Reaction, Microarray, Sequencing, Electrophoresis, and Others), by Application (Neurology, Oncology, Infectious Diseases, Pain Management, and Others), by End-User (Hospitals & Clinics, Academic Institutes, Research Institutes, and Others) and by Region – Global Industry Sizing, Growth, Trend, Opportunity, and Forecast...

Pharmacogenomics Market Research Report Straits Research has released a new report titled Pharmacogenomics by Product type, application, Geographic trends, and Distribution Channel: Industry Opportunity and Analysis. The Pharmacogenomics Market Share report provides an in-depth analysis of key growth strategies, drivers, opportunities, key segments, Porter’s Five Forces...

Pharmacogenomics Market Summary 2022-2030 The Pharmacogenomics research report covers global current market size estimation, market situation, structure, products, leading industry players, segmentation by types, and applications. The Pharmacogenomics market study focuses on the characteristics that have a significant influence on the Pharmacogenomics market and might have a massive effect on...